Neurocognitive disorders and hypertension occur commonly with aging. While, by definition, older adults are at high cardiovascular risk, there is no guideline exist currently on blood pressure management of elderly hypertension. However, studies have shown that in aging adults, high blood pressure helps prevent against cognitive decline, and low blood pressure on antihypertensive drugs could accelerate it. This study aims at investigating if pharmacological treatment of hypertension in the very elderly is influenced by presence and severity of neurocognitive disorders. Our research hypothesis is that the drug management of hypertension in patients 80 years of age or older more is all the less aggressive as the neurocognitive disorders are advanced.
Study Type
OBSERVATIONAL
Enrollment
353
number of hypertensive drugs
Centre Hospitalier Régional Universitaire de Nancy
Nancy, France
number of antihypertensive agents
among ACEI/ARB2, calcium channel blocker, thiazides and related, central antihypertensive beta blocker
Time frame: during inclusion
class of antihypertensive medications
among ACEI/ARB2, calcium channel blocker, thiazides and related, central antihypertensive beta blocker
Time frame: during inclusion
systolic and diastolic blood pressure
blood pressure measured with upper arm cuffs
Time frame: during inclusion
orthostatic hypotension
a systolic blood pressure decrease of at least 20 mm Hg or a diastolic blood pressure decrease of at least 10 mm Hg within three minutes of standing
Time frame: during inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.